Literature DB >> 26984039

Cortical and subcortical modulation of pain.

Milena De Felice1, Michael H Ossipov2.   

Abstract

Pain is more than merely nociception and response, but rather it encompasses emotional, behavioral and cognitive components that make up the pain experience. With the recent advances in imaging techniques, we now understand that nociceptive inputs can result in the activation of complex interactions among central sites, including cortical regions that are active in cognitive, emotional and reward functions. These sites can have a bimodal influence on the serotonergic and noradrenergic descending pain modulatory systems via communications among the periaqueductal gray, rostral ventromedial medulla and pontine noradrenergic nuclei, ultimately either facilitating or inhibiting further nociceptive inputs. Understanding these systems can help explain the emotional and cognitive influences on pain perception and placebo/nocebo effects, and can help guide development of better pain therapeutics.

Entities:  

Keywords:  PAG; RVM; descending modulation; endogenous opioid; gabapentin; neuropathic pain; nociception; noradrenergic pain modulation; noradrenergic projections; pain matrix; serotonergic pain modulation

Mesh:

Year:  2016        PMID: 26984039     DOI: 10.2217/pmt.15.63

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  10 in total

1.  Activation of the Intrinsic Pain Inhibitory Circuit from the Midcingulate Cg2 to Zona Incerta Alleviates Neuropathic Pain.

Authors:  Ting-Ting Hu; Ran-Ran Wang; Yu Du; Fang Guo; Yu-Xing Wu; Yi Wang; Shuang Wang; Xiang-Yao Li; Shi-Hong Zhang; Zhong Chen
Journal:  J Neurosci       Date:  2019-10-11       Impact factor: 6.167

2.  Noninvasive brain stimulation combined with exercise in chronic pain: a systematic review and meta-analysis.

Authors:  Alejandra Cardenas-Rojas; Kevin Pacheco-Barrios; Stefano Giannoni-Luza; Oscar Rivera-Torrejon; Felipe Fregni
Journal:  Expert Rev Neurother       Date:  2020-03-14       Impact factor: 4.618

Review 3.  Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain.

Authors:  Giacomo Rossettini; Elisa Carlino; Marco Testa
Journal:  BMC Musculoskelet Disord       Date:  2018-01-22       Impact factor: 2.362

4.  The Chemokine Receptor CXCR2 Supports Nociceptive Sensitization after Traumatic Brain Injury.

Authors:  De-Yong Liang; Xiaoyou Shi; Peng Liu; Yuan Sun; Peyman Sahbaie; Wen-Wu Li; David C Yeomans; J David Clark
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

5.  The developmental emergence of differential brainstem serotonergic control of the sensory spinal cord.

Authors:  F Schwaller; A H Kanellopoulos; M Fitzgerald
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

Review 6.  Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson's Disease.

Authors:  Tino Prell
Journal:  Front Neurol       Date:  2018-03-12       Impact factor: 4.003

7.  Functional magnetic resonance imaging: cerebral function alterations in subthreshold and suprathreshold spinal cord stimulation.

Authors:  Sander De Groote; Mats De Jaeger; Peter Van Schuerbeek; Stefan Sunaert; Ronald Peeters; Dirk Loeckx; Lisa Goudman; Patrice Forget; Ann De Smedt; Maarten Moens
Journal:  J Pain Res       Date:  2018-10-24       Impact factor: 3.133

Review 8.  CGRP and the Trigeminal System in Migraine.

Authors:  Smriti Iyengar; Kirk W Johnson; Michael H Ossipov; Sheena K Aurora
Journal:  Headache       Date:  2019-04-14       Impact factor: 5.887

Review 9.  Lasmiditan mechanism of action - review of a selective 5-HT1F agonist.

Authors:  David B Clemow; Kirk W Johnson; Helen M Hochstetler; Michael H Ossipov; Ann M Hake; Andrew M Blumenfeld
Journal:  J Headache Pain       Date:  2020-06-10       Impact factor: 7.277

10.  Ventrolateral periaqueductal gray exogenous and endogenous histamine attenuates sciatic nerve chronic constriction injury-induced neuropathic pain through opioid receptors.

Authors:  Sara Salimi; Esmaeal Tamaddonfard; Farhad Soltanalinejad-Taghiabad
Journal:  Vet Res Forum       Date:  2021-12-15       Impact factor: 0.950

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.